Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;88(6):2591-2604.
doi: 10.1111/bcp.15241. Epub 2022 Feb 7.

Postoperative administration of ketorolac compared to other drugs for pain control after third molar surgery: A meta-analysis of double-blind, randomized, clinical trials

Affiliations
Free article
Review

Postoperative administration of ketorolac compared to other drugs for pain control after third molar surgery: A meta-analysis of double-blind, randomized, clinical trials

Mario Alberto Isiordia-Espinoza et al. Br J Clin Pharmacol. 2022 Jun.
Free article

Abstract

Aims: The aim of this study was to evaluate the analgesic effectiveness and adverse reactions of ketorolac in comparison with other drugs when administered postoperatively after third molar surgery.

Methods: PubMed and Google Scholar were utilized to search for articles comparing the efficacy and safety of ketorolac and other analgesic agents after third molar surgery. Data from papers with a lower risk of bias were recorded. The overall evaluation of analgesia onset, general and subgroup evaluation of the number of patients requiring rescue analgesic medication, general and subgroup assessment of the study medication (satisfaction on the study drugs), and the overall estimation of adverse effects were performed using the Review Manager Software 5.3 to analyse the data and obtain the meta-analysis plot.

Results: The subgroup evaluation of the study medication showed that patients who received ketorolac 30 mg were more satisfied than those who were given parecoxib 1 mg (odds ratio [OR] = 8.57, 95% confidence interval [CI] = 3.66-20.08, P = .00001), parecoxib 2 mg (OR = 7.17, 95% CI = 2.88-17.86, P = .0001), parecoxib 5 mg (OR = 3.03, 95% CI = 1.69-5.41, P = .0002), and parecoxib 10 mg (OR = 2.42, 95% CI = 1.36-4.32, P = .003). Moreover, patients who received ketorolac reported fewer adverse reactions compared with those who had received opioid analgesics (OR = 0.14, 95% CI = 0.32-1.76, P = .0001).

Conclusions: The data from this study demonstrates that the postoperative administration of ketorolac 30 mg presents better results on patient satisfaction when compared to parecoxib 1 mg to 10 mg, and presents a similar satisfaction to parecoxib 20 mg following third molar removal.

Keywords: diclofenac, opioid analgesics; ketorolac; parecoxib; third molar surgery.

PubMed Disclaimer

References

REFERENCES

    1. Franco-de la Torre L, Figueroa-Fernández NP, Franco-González DL, Alonso-Castro ÁJ, Rivera-Luna F, Isiordia-Espinoza MA. A meta-analysis of the analgesic efficacy of single-doses of ibuprofen compared to traditional non-opioid analgesics following third molar surgery. Pharmaceuticals (Basel). 2021;14(4):360. doi:10.3390/ph14040360
    1. Isiordia-Espinoza MA, Franco-González MA, Alonso-Castro ÁJ, Franco-de la Torre L. Analgesic effectiveness and safety of celecoxib versus non-opioid active controls after third molar surgery: a meta-analytical evaluation. J Stomatol Oral Maxillofac Surg. 2021;S2468-7855(21)00141-5. doi:10.1016/j.jormas.2021.06.015
    1. Carrasco-Labra A, Brignardello-Petersen R, Yanine N, Araya I, Guyatt G Secondary versus primary closure techniques for the prevention of postoperative complications following removal of impacted mandibular third molars: a systematic review and meta-analysis of randomized controlled trials. J Oral Maxillofac Surg. 2012;70(8):e441-e457. doi:10.1016/j.joms.2012.03.017
    1. Al-Delayme RMA. Randomized clinical study comparing piezoelectric surgery with conventional rotatory osteotomy in mandibular third molars surgeries. Saudi Dent J. 2021;33(1):11-21. doi:10.1016/j.sdentj.2019.11.010
    1. Litvak KM, McEvoy GK. Ketorolac, an injectable nonnarcotic analgesic. Clin Pharm. 1990;9(12):921-935.

MeSH terms

LinkOut - more resources